Biogen soars on promising results from Alzheimer's drug trial
Dr. Eric Siemers, Alzheimer's Assoc. Research Roundtable founding member, and Salim Syed, Mizuho analyst, discuss what's so promising about Biogen's new Alzheimer's drug trial.
04:09
Fri, Jul 6 20183:32 PM EDT
- Subscribe to CNBC PRO
- Licensing & Reprints
- CNBC Councils
- Supply Chain Values
- CNBC on Peacock
- Advertise With Us
- Join the CNBC Panel
- Digital Products
- News Releases
- Closed Captioning
- Corrections
- About CNBC
- Internships
- Site Map
- Podcasts
- Ad Choices
- Careers
- Help
- Contact
© 2020 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by 